PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29565454-0	2018	SIRT5 as a biomarker for response to anthracycline-taxane-based neoadjuvant chemotherapy in triple-negative breast cancer.	taxane	51-57	sirtuin 5	Homo sapiens	0-5	
29565454-6	2018	Thus, we speculated that SIRT5 may be a potential predictive marker of the response to anthracycline-taxane-based chemotherapy.	taxane	101-107	sirtuin 5	Homo sapiens	25-30	
29565454-11	2018	In conclusion, the present study revealed SIRT5 as a biomarker for response to anthracycline-taxane-based NAC in patients with TNBC and identified a series of novel biological functions of SIRT5 in breast cancer.	taxane	93-99	sirtuin 5	Homo sapiens	42-47